Abingworth LLP 13F Holdings · last filed Q4 2022
Abingworth LLP reported 19 securities worth $306.92M in its SEC 13F filing for Q4 2022 (period ended 2022-12-31). Top holdings: PCVX (31.54%), VRNA (20.92%), VERA (18.66%). Among its top 25 positions this quarter: 1 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PCVX | VAXCYTE INC | $96.8M | 31.54% | 2.0M | Trimmed |
| 2 | VRNA | VERONA PHARMA PLC | $64.2M | 20.92% | 2.5M | Hold |
| 3 | VERA | VERA THERAPEUTICS INC | $57.3M | 18.66% | 3.0M | Hold |
| 4 | HLVX | HILLEVAX INC | $30.8M | 10.02% | 1.8M | Hold |
| 5 | ACET | ADICET BIO INC | $18.9M | 6.16% | 2.1M | Hold |
| 6 | PHAT | PHATHOM PHARMACEUTICALS INC | $16.1M | 5.25% | 1.4M | Hold |
| 7 | OKUR | RENEO PHARMACEUTICALS INC | $4.8M | 1.57% | 2.1M | Hold |
| 8 | SIENQ | SIENTRA INC | $3.4M | 1.11% | 1.7M | Hold |
| 9 | JSPR | JASPER THERAPEUTICS INC | $2.7M | 0.89% | 5.6M | Hold |
| 10 | SLNO | SOLENO THERAPEUTICS INC | $2.4M | 0.78% | 1.2M | Hold |
| 11 | NCNA | NUCANA PLC | $2.2M | 0.72% | 3.3M | Hold |
| 12 | EFTR | EFFECTOR THERAPEUTICS INC | $2.1M | 0.67% | 4.8M | Hold |
| 13 | SPRB | SPRUCE BIOSCIENCES INC | $2.0M | 0.64% | 1.8M | Hold |
| 14 | PRTK | PARATEK PHARMACEUTICALS INC | $1.9M | 0.63% | 1.0M | Hold |
| 15 | CBAY | CYMABAY THERAPEUTICS INC | $821,596 | 0.27% | 131,036 | Hold |
| 16 | XCUR | EXICURE INC | $323,881 | 0.11% | 281,636 | Hold |
| 17 | AGLE | AEGLEA BIOTHERAPEUTICS INC | $108,225 | 0.04% | 240,500 | Hold |
| 18 | MTEM | MOLECULAR TEMPLATES INC | $66,000 | 0.02% | 200,000 | Hold |
| 19 | OBSVF | OBSEVA SA | $12,760 | 0.00% | 87,999 | Hold |
Source: SEC Form 13F filings · as of 2022-12-31
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR